(ACIU) |
| 0 (0%) 10-09 22:52 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 4.66 |
| Resistance 1: | 3.99 |
| Pivot price: | 3.08 |
| Support 1: | 2.85 |
| Support 2: | 2.14 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -48670000.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 58.129 |
| Profit Margin (%) | -174.67 |
| Operating Margin (%) | -1.00 |
| Return on Assets (ttm) | 484.5 |
| Return on Equity (ttm) | -14.6 |
Company news
Thu, 09 Oct 2025
Why AC Immune (ACIU) Is Up 15.8% After Promising Early Trial Data for Alzheimer’s Vaccine Candidate - Yahoo Finance
Wed, 08 Oct 2025
AC Immune (ACIU) Is Up 24.2% After Positive ACI-35.030 Trial Publication in Alzheimer's Disease - simplywall.st
Tue, 07 Oct 2025
AC Immune (NasdaqGM:ACIU): Exploring Valuation Following Promising Phase 1b/2a Alzheimer’s Data Publication - simplywall.st
Tue, 07 Oct 2025
A Look at AC Immune’s (NasdaqGM:ACIU) Valuation After New Alzheimer’s Immunotherapy Trial Results - Yahoo Finance
Tue, 07 Oct 2025
AC Immune Gears Up For Pipeline Milestones - Will Upcoming Data Catalysts Spark Investor Interest? - RTTNews
Tue, 07 Oct 2025
Is ACIU a good long term investment - Resistance Zone Identification & Superior Return Stocks - earlytimes.in
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
